Lahusen, A., Lutz, M. P., Karthaus, M., Kirchner, M., Kluck, K., Wisser, S., Cheung, P. F., Ansorge, N., Burkart, C., Decker, T., Weikersthal, L. F. V., Geer, T., Gerhardt, A., Budczies, J., Siveke, J. T., Tannapfel, A., Seufferlein, T., Stenzinger, A., Eiseler, T., Ettrich, T. J. (2025). A PBMC and machine learning based biomarker signature to predict second line chemotherapy success in advanced PDAC: Translational data of the PREDICT trial—A prospective, multicenter, trial of the AIO Pancreatic Cancer Group (AIO-PAK-0216).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4187